Infusion Clinic
Schedule appointmentTherapies
Below, you'll find a list of therapies we commonly administer. Each is carefully selected to address various needs and conditions, ensuring precise care and effective treatment for our valued patients.
Aldurazyme
Aldurazyme (LARONIDASE) treats mucopolysaccharidosis I (MPS I). It works by replacing an enzyme normally made by the body, which reduces the buildup of complex sugars in the body. This decreases symptoms.
Briumvi
Briumvi (UBLITUXIMAB) treats multiple sclerosis (MS). It works by slowing down an overactive immune system, which prevents or delays worsening symptoms. It also decreases the number of flare-ups. It is not a cure for MS. It is a monoclonal antibody.
Fabrazyme
Fabrazyme (AGALSIDASE BETA) is used to replace an enzyme that is missing in patients with Fabry disease. It is not a cure.
Gammagard (IVIG)
Gammagard (IVIG) helps to prevent or reduce the severity of certain infections in patients who are at risk. This medicine is collected from the pooled blood of many donors. It is used to treat immune system problems, thrombocytopenia, and Kawasaki syndrome.
Gamunex (IVIG)
Gamunex (IVIG) is used to treat primary humoral immunodeficiency, idiopathic thrombocytopenic purpura, and chronic inflammatory demyelinating polyneuropathy.
Inflectra
Inflectra (INFLIXIMAB-DYYB) is used to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis and ulcerative colitis. Inflectra is a biosimilar for Remicade (Infliximab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety.
Lemtrada
Lemtrada (ALEMTUZUMAB) treats multiple sclerosis (MS). It works by slowing down an overactive immune system, which prevents or delays worsening symptoms. It also decreases the number of flare-ups. It is not a cure for MS.
Leqembi
Leqembi (LECANEMAB or LECANEMAB-IRMB) treats Alzheimer disease. It works by decreasing the buildup of amyloid, a protein that may cause Alzheimer disease. This may slow down the worsening of symptoms. It is a monoclonal antibody.
Ocrevus
Ocrevus (OCRELIZUMAB) treats multiple sclerosis (MS). It works by slowing down an overactive immune system, which prevents or delays worsening symptoms. It also decreases the number of flare-ups. It is not a cure for MS. It belongs to a group of medications called monoclonal antibodies.
Onpattro
Onpattro (PATISIRAN) treats nerve pain, tingling, or numbness in the hands or feet in people with hereditary transthyretin-mediated amyloidosis (hATTR). It works by reducing the buildup of a protein in your body. This decreases the symptoms of hATTR.
Prolia
Prolia (DENOSUMAB) is used to treat osteoporosis in women after menopause and in men.
Reclast
Reclast (ZOLEDRONIC ACID) is used to treat Paget's disease and osteoporosis in women.
Remicade
Remicade (INFLIXIMAB) is used to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis and ulcerative colitis. Remicade is also available as a biosimilar. Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety.
Rituxan
Rituxan (RITUXIMAB) is used to treat rheumatoid arthritis, leukemia, and non-hodgkin's lymphoma. Rituxan is also available as a biosimilar. Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety.
Soliris
Soliris (ECULIZUMAB) treats certain blood conditions that can cause low levels of red blood cells (anemia) and blood clots, such as atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). It works by slowing down an overactive immune system, which reduces the breakdown of red blood cells. It also prevents blood cells (platelets) from forming a clot. It may also be used to treat a condition that causes muscles to easily weaken or fatigue (myasthenia gravis).
Tepezza
Tepezza (TEPROTUMUMAB) treats thyroid eye disease. It works by decreasing inflammation. This decreases symptoms, such as redness, swelling, irritation, or bulging of the eyes. It may also improve double vision. It is a monoclonal antibody.
Tysabri
Tysabri (NATALIZUMAB) treats multiple sclerosis (MS). It works by slowing down an overactive immune system, which prevents or delays worsening symptoms. It also decreases the number of flare-ups. It may also be used to treat Crohn's disease. It is a monoclonal antibody.
Ultomiris
Ultomiris (RAVULIZUMAB) treats certain blood conditions that can cause low levels of red blood cells (anemia) and blood clots, such as atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). It works by slowing down an overactive immune system, which reduces the breakdown of red blood cells. It also prevents blood cells (platelets) from forming a clot. It may also be used to treat a condition that causes muscles to easily weaken or fatigue (myasthenia gravis). It is a monoclonal antibody.
Vyepti
Vyepti (EPTINEZUMAB) prevents migraines. It works by blocking a substance in the body that causes migraines. It is a monoclonal antibody.
Vyvgart
Vyvgart (EFGARTIGIMOD ALFA) treats myasthenia gravis, a condition that causes muscles to easily weaken or fatigue. It works by decreasing muscle weakness and loss of movement.
Xolair
Xolair (OMALIZUMAB) prevents the symptoms of asthma. It may also be used to treat nasal polyps, chronic hives, and food allergies. It works by reducing the release of substances in your body that cause allergy symptoms. This decreases inflammation of the airways and makes it easier to breathe. It also reduces itching. It can also reduce the body’s response to some food allergens after accidental exposure. It is a monoclonal antibody.
Menu